Soluble CD163 as a prognostic biomarker in B-cell chronic lymphocytic leukemia.
a Department of Hematology , Aarhus University Hospital , Denmark.
Line
L
Nederby
a Department of Hematology , Aarhus University Hospital , Denmark.|b Department of Hematology , Aalborg University Hospital , Denmark.
Anne S
AS
Roug
c Region of Northern Denmark , Denmark.
Signe S
SS
Knudsen
d Department of Biomedicine , Aarhus University , Denmark.
Anni
A
Skovbo
a Department of Hematology , Aarhus University Hospital , Denmark.
Eigil
E
Kjeldsen
e Department of Clinical Biochemistry , Aarhus University Hospital , Denmark.
Holger J
HJ
Moller
d Department of Biomedicine , Aarhus University , Denmark.
Marianne
M
Hokland
D015703:Antigens, CD / Q000097:blood*; D015214:Antigens, Differentiation, Myelomonocytic / Q000097:blood*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D002869:Chromosome Aberrations; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D016130:Immunophenotyping; D053208:Kaplan-Meier Estimate; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality*; D011379:Prognosis; D011956:Receptors, Cell Surface / Q000097:blood*; D016896:Treatment Outcome; D000098902:CD163 Antigen
D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D014408:Biomarkers, Tumor; D000098902:CD163 Antigen; D011956:Receptors, Cell Surface